MicuRx Pharmaceuticals Company

MicuRx discovers and develops novel antibiotics to prevent and treat drug-resistant bacterial infections.
MicuRx discovers and develops novel antibiotics to combat drug resistant bacterial infections. Founded in 2007, MicuRx employs a hybrid U.S./China business model to capitalize on the global opportunities afforded by U.S. research and development coupled with the high-quality, cost-efficient infrastructure and scientific resources available in China. This hybrid business model enables MicuRx to implement an accelerated global development strategy with a goal of completing Phase II trials for its drug candidates in both the United States and China.
Technology: Preventive Medicine
Industry: Preventive medicine
Headquarters: Hayward
Founded Date: 2007
Employees Number: 11-50
Funding Status: Late Stage Venture

Visit Website
Register and Claim Ownership